Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Dow
Boehringer Ingelheim
Harvard Business School
Colorcon

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

Erythromycin - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for erythromycin and what is the scope of freedom to operate?

Erythromycin is the generic ingredient in fifty-two branded drugs marketed by Mayne Pharma, Parke Davis, Warner Chilcott Llc, Hospira, Arbor Pharms Llc, Barr, Mylan, Altana, Fougera Pharms, Perrigo Co, Teligent Pharma Inc, Syosset, Akorn, Bausch And Lomb, Perrigo Co Tennessee, Pharmaderm, Pharmafair, Dista, Bausch, Paddock Llc, Taro, Arbor Pharms Inc, Merz Pharms, MLV, Hi Tech Pharma, Alpharma Us Pharms, Lilly, Perrigo New York, Renaissance Pharma, Wockhardt Bio Ag, Dow Pharm, Westwood Squibb, Ivax Sub Teva Pharms, Johnson And Johnson, Amneal Pharms Co, Solvay, Robins Ah, Watson Labs, Acp Nimble, Life Labs, Ani Pharms Inc, Ross Labs, Pharmacia And Upjohn, Naska, Wyeth Ayerst, Alra, Abbott, Elkins Sinn, Abraxis Pharm, Baxter Hlthcare, Teva Parenteral, Bristol, Warner Chilcott, Lederle, Purepac Pharm, Bristol Myers Squibb, and Pfizer, and is included in one hundred and twenty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are one hundred and three drug master file entries for erythromycin. Thirty-one suppliers are listed for this compound. There is one tentative approval for this compound.

Drug Prices for erythromycin

See drug prices for erythromycin

Drug Sales Revenue Trends for erythromycin

See drug sales revenues for erythromycin

Recent Clinical Trials for erythromycin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Prof Dr Jan TackN/A
Woman'sPhase 4
Beijing Children's HospitalN/A

See all erythromycin clinical trials

Generic filers with tentative approvals for ERYTHROMYCIN
Applicant Application No. Strength Dosage Form
  Start Trial  Start Trial500MGTABLET;ORAL
  Start Trial  Start Trial250MGTABLET;ORAL

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for erythromycin
Medical Subject Heading (MeSH) Categories for erythromycin
Synonyms for erythromycin
(-)-ERYTHROMYCIN
(-)-Erythromycin, 98%
(-)-Erythromycin, Eur.Ph.
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,
(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-
114-07-8
114E078
215031-94-0
374700-25-1
44496-EP2272846A1
44496-EP2275422A1
44496-EP2292608A1
44496-EP2305644A1
44496-EP2308866A1
44496-EP2311814A1
44496-EP2311828A1
44496-EP2380568A1
63937KV33D
82343-12-2
8HPH7ND0LN
9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
A/T/S
AB00051981_09
AB00051981_10
Abboticin
Abomacetin
AC-12744
AC-12901
AC1L1ZUR
Acneryne
Acnesol
ACT03320
AI3-50138
Ak-Mycin
Akne Cordes Losung
Akne-Mycin
Akne-mycin (TN)
Aknederm Ery Gel
Aknemycin
Aknin
AKOS015895249
AustriaS
BC205124
BDBM50344942
Benzamycin
BIDD:GT0017
BPBio1_000312
BRD-K63550407-001-13-5
BRD-K63550407-028-03-9
BSPBio_000282
BSPBio_002480
C-23475
C-Solve-2
C01912
CAS-114-07-8
CC-27517
CCG-38992
CCRIS 9078
CHEBI:42355
CHEMBL3735423
CHEMBL532
CPD000544946
CS-2168
D00140
DB00199
Del-Mycin
Derimer
Deripil
DivK1c_000294
DivK1c_000397
DivK1c_000702
Dotycin
DSSTox_CID_2991
DSSTox_GSID_22991
DSSTox_RID_76820
DTXSID4022991
Dumotrycin
E-3250
E-Base
E-Base (base)
E-Glades
E-Mycin
E-Mycin (base)
E-mycin, Erythrocin
E-Solve 2
E0751
EC 204-040-1
EINECS 204-040-1
EM-A
Emgel
Emu-V
Emu-Ve
Emuvin
Emycin
Endoeritrin
Erecin
Erimycin-T
Erisone
Eritomicina
Eritrocina
Eritromicina
Eritromicina [INN-Spanish]
Ermycin
Eros
erthromycin
ERY
Ery-B
Ery-Diolan
Ery-maxin
Ery-Sol
Ery-Tab
Ery-Tab (base)
Eryacne
Eryacnen
ERYC
ERYC (base)
Eryc (TN)
Eryc 125
Eryc Sprinkles
Eryc-125
Eryc-250
Erycen
Erycette
Erycin
Erycinum
Eryderm
Erydermer
Erygel
Erygel (TN)
Eryhexal
Erymax
Erymed
Erysafe
Erytab
Erythra-Derm
erythro
Erythro-Statin
Erythro-Teva
Erythrocin
Erythrocin stearate
Erythroderm
Erythrogran
Erythroguent
Erythromast 36
Erythromid
Erythromycin (JP17/USP/INN)
Erythromycin (mixture of A,B,C)
Erythromycin [USP:INN:BAN:JAN]
Erythromycin A
Erythromycin A, B + C
Erythromycin A, British Pharmacopoeia (BP) Reference Standard
Erythromycin A, European Pharmacopoeia (EP) Reference Standard
Erythromycin base
Erythromycin C-13
Erythromycin glucoheptonate
Erythromycin Lactate
Erythromycin standard solution, 1 mg/mL in H2O
ERYTHROMYCIN STEARATE
erythromycin-A
Erythromycin, Antibiotic for Culture Media Use Only
Erythromycin, BioReagent, suitable for cell culture
Erythromycin, Biotechnology Performance Certified
Erythromycin, for microbiological assay, European Pharmacopoeia (EP) Reference Standard
Erythromycin, labeled with carbon-13
Erythromycin, meets USP testing specifications
Erythromycin, N-demethyl-N-(methyl-11C)-
Erythromycin, Pharmaceutical Secondary Standard; Certified Reference Material
Erythromycin, plant cell culture tested, ~98%
Erythromycin, potency: >=850 mug per mg
Erythromycin, tested according to Ph.Eur.
Erythromycin, United States Pharmacopeia (USP) Reference Standard
Erythromycine
Erythromycine [INN-French]
Erythromycines
Erythromycinum
Erythromycinum [INN-Latin]
Erytop
Erytrociclin
GTPL1456
HMS1920M04
HMS2091D05
HMS2095O04
HMS3712O04
HMS500O16
HSDB 3074
HY-B0220
IDI1_000294
IDI1_000397
IDI1_000702
Ilocaps
Ilosone (estolate)
Iloticina
Ilotycin
Ilotycin gluceptate
Ilotycin T.S.
Inderm
Inderm Gel
IndermRetcin
KBio1_000294
KBio1_000397
KBio1_000702
KBio2_000555
KBio2_001139
KBio2_003123
KBio2_003707
KBio2_005691
KBio2_006275
KBioGR_001175
KBioSS_000555
KBioSS_001139
Kesso-Mycin
Latotryd
Lederpax
LMPK04000006
LS-187077
MCULE-4566208867
Mephamycin
Mercina
MFCD00084654
MLS001066618
MolPort-002-507-378
N-Methylerythromycin A
NCGC00094670-01
NCGC00179619-01
NCGC00179619-02
NCGC00179619-03
NCGC00254234-01
NCI-C55674
NINDS_000294
NINDS_000397
NINDS_000702
NSC 55929
NSC-756759
NSC55929
NSC756759
Oftalmolosa Cusi Eritromicina
Oftamolets
Paediathrocin
Pantoderm
Pantodrin
Pantomicina
Pce (TN)
PCE Dispertab (base)
Pfizer-E
Pharmakon1600-01500280
Pharyngocin
Prestwick_205
Prestwick3_000151
Primacine
Propiocine
Proterytrin
R-P Mycin
Retcin
RKL10096
Robimycin
Romycin
SAM002643510
Sans-acne
Sansac
SBI-0051368.P003
SC-13736
SCHEMBL2601
Sentry AQ mardel maracyn
Skid Gel E
SMP1_000119
SMR000544946
SPBio_000778
SPBio_001226
Spectrum_000115
Spectrum_000659
SPECTRUM1500280
Spectrum2_000759
Spectrum2_001263
Spectrum4_000538
Spectrum5_001596
SR-01000799155
SR-01000799155-2
SR-05000001618
SR-05000001618-1
SR-05000001618-2
Staticin (TN)
Stiemicyn
Stiemycin
T-Stat
T-stat (TN)
Taimoxin-F
Theramycin Z
Tiloryth
Tiprocin
Torlamicina
Tox21_111311
Tox21_111869
Tox21_300515
Udima Ery Gel
ULGZDMOVFRHVEP-RWJQBGPGSA-N
ULGZDMOVFRHVEP-UHFFFAOYSA-N
UNII-63937KV33D
UNII-8HPH7ND0LN
Wemid
Wyamycin S
ZINC85534336
ZX-AFC000696

US Patents and Regulatory Information for erythromycin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmaderm ERYTHROMYCIN erythromycin OINTMENT;OPHTHALMIC 062446-001 Sep 26, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Bausch And Lomb ERYTHROMYCIN erythromycin OINTMENT;OPHTHALMIC 064067-001 Jul 29, 1994 AT RX No No   Start Trial   Start Trial   Start Trial
Arbor Pharms Llc ERY-TAB erythromycin TABLET, DELAYED RELEASE;ORAL 062298-001 Approved Prior to Jan 1, 1982 AB RX No No   Start Trial   Start Trial   Start Trial
Dista ILOSONE erythromycin estolate TABLET, CHEWABLE;ORAL 061895-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Lilly ILOSONE erythromycin estolate SUSPENSION;ORAL 050010-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Arbor Pharms Llc ERYPED erythromycin ethylsuccinate GRANULE;ORAL 050207-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Hospira ERYTHROCIN erythromycin lactobionate INJECTABLE;INJECTION 050182-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
McKesson
Boehringer Ingelheim
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.